-
Cochin Shipyard
2,547.25 2,977.10(%) -
Azad Engineering
1,561.00 1,128.40(%) -
Garden Reach Sh.
3,199.05 1,180.10(%) -
HDFC Bank
1,996.30 1,996.30(%) -
Reliance Industr
1,451.35 1,608.95(%) -
Reliance Power
63.13 63.39(%) -
Natl. Aluminium
190.90 263.10(%) -
HFCL
92.19 171.00(%) -
Ramkrishna Forg.
674.40 1,064.00(%) -
Suzlon Energy
66.10 46.00(%) -
IDFC First Bank
72.25 84.50(%) -
Sika Interplant
1,265.00 399.96(%) -
Multi Comm. Exc.
7,529.95 7,529.95(%) -
St Bk of India
816.45 898.80(%) -
Mazagon Dock
3,380.30 1,417.20(%) -
Hindustan Zinc
510.75 717.10(%) -
ICICI Bank
1,461.95 1,471.10(%) -
REC Ltd
417.30 653.90(%) -
Eternal Ltd
264.10 304.50(%) -
Bharat Electron
389.05 240.15(%)
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
Alkem Laboratories Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln
- Indian Private
- BSE Code : 19299.0
- ISIN : INE540L01014
-
Today’s Low
4,811.00 -
Today’s High
4,923.00

-
Open
4,868.00 -
Perv Close
4,843.50 -
52W Low
4,491.65 -
52W High
6,439.90
Key Indicators
-
P/E(TTM)
27.83
-
Mar.Cap (₹Cr.)
58,138.48
-
Div & Yield %
0.76
-
Book Value(₹)
984.46
-
Debt-Equity Ratio
0.39
-
AGM Date
06-Jun-2025
-
EPS
174.78
-
P/E Ratio
27.83
Financials Ratios
-
Debt-Equity Ratio
0.15
-
Mar.Cap (₹Cr.)
58,138.48
-
RONW (%)
18.72
-
ROCE (%)
18.29
Score Board
-
Equity (₹ in Cr.)
23.91
-
BV (₹)
984.50
-
Sales( ₹ in Cr.)
8,813.44
-
NP (in Cr.)
2,089.72
-
NP Var(%)
16.0
-
Div%
1850.0
-
CPS (₹)
198.50
-
EPS (₹)
174.80
-
Traded Value (₹ in Lakhs)
58,167.77
-
52 Week High
6,439.90
-
52 Week Low
4,491.65
-
Price BSE
4865.0
-
Price NSE
4,863.00
-
Market Capital( in Cr.)
58,167.77
-
P/C Ratio
24.50
-
P/E Ratio
27.80
-
Price Vs.BV
174.80
-
04-Jun-2025( 11:00)
Hot Pursuit - Volum... - <p>Tata Technologies Ltd, Adit...
-
30-May-2025( 09:11)
Results - Announcements - Alkem... - Net profit of Alkem Laboratori...
-
29-May-2025( 05:29)
Results - Announcements - Alkem... - Net profit of Alkem Laboratori...
-
29-May-2025( 05:45)
Corporate News - Alkem... - Alkem Laboratories announced t...
Navigate The Market With Confidence
Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions
Financials
All Values are in (₹Cr)Particulars(INCOME) | 2024 Mar | 2023 Mar | 2022 Mar | 2021 Mar | 2020 Mar | 2019 Mar |
---|---|---|---|---|---|---|
INCOME : | ||||||
Sales Turnover | 9,747.72 | 9,054.55 | 8,829.81 | 7,219.68 | 6,677.08 | 5,714.09 |
Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Sales | 9,747.72 | 9,054.55 | 8,829.81 | 7,219.68 | 6,677.08 | 5,714.09 |
Other Income | 305.99 | 266.29 | 199.89 | 190.01 | 95.98 | 67.58 |
Stock Adjustments | 71.31 | -257.73 | 360.90 | 301.29 | 33.69 | -86.56 |
Total Income | 10,125.02 | 9,063.11 | 9,390.60 | 7,710.98 | 6,806.75 | 5,695.11 |
EXPENDITURE : | ||||||
Raw Materials | 3,878.63 | 3,572.91 | 3,926.79 | 2,966.31 | 2,584.25 | 2,185.31 |
Power and Fuel Cost | 123.85 | 126.32 | 129.53 | 100.12 | 106.08 | 99.09 |
Employee Cost | 1,560.28 | 1,516.22 | 1,434.49 | 1,158.72 | 1,066.76 | 960.09 |
Other Manufacturing Expenses | 439.03 | 361.12 | 399.80 | 280.51 | 276.78 | 270.72 |
Selling and Administration Expenses | 1,608.76 | 1,739.71 | 1,438.80 | 1,007.42 | 1,160.90 | 1,013.41 |
Miscellaneous Expenses | 307.18 | 103.59 | 50.94 | 71.74 | 48.35 | 53.20 |
Employee Benefit Expenses | 1,560.28 | 1,516.22 | 1,434.49 | 1,158.72 | 1,066.76 | 960.09 |
Less: Preoperative Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Expenses | 7,917.73 | 7,419.87 | 7,380.35 | 5,584.82 | 5,243.12 | 4,581.82 |
Operating Profit | 2,207.29 | 1,643.24 | 2,010.25 | 2,126.16 | 1,563.63 | 1,113.29 |
Interest | 81.91 | 86.40 | 37.90 | 42.93 | 38.71 | 28.26 |
Gross Profit | 2,125.38 | 1,556.84 | 1,972.35 | 2,083.23 | 1,524.92 | 1,085.03 |
Depreciation | 244.35 | 229.85 | 218.98 | 198.93 | 186.84 | 141.07 |
Profit Before Tax | 1,881.03 | 1,326.99 | 1,753.37 | 1,884.30 | 1,338.08 | 943.96 |
Current Tax | 333.28 | 227.52 | 303.82 | 331.83 | 246.95 | 200.41 |
Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Deferred Tax | -199.40 | -35.00 | -91.70 | -132.61 | -173.29 | -56.29 |
Reported Net Profit | 1,747.15 | 1,134.47 | 1,541.25 | 1,685.08 | 1,264.42 | 799.84 |
Extraordinary Items | -54.86 | -10.24 | 1.82 | 16.49 | 3.07 | -1.43 |
Adjusted Net Profit | 1,802.01 | 1,144.71 | 1,539.43 | 1,668.59 | 1,261.35 | 801.27 |
Adjustment below Net Profit | 0.00 | 0.00 | 0.00 | 0.00 | -73.21 | -36.45 |
P & L Balance brought forward | 7,431.77 | 6,823.39 | 5,700.62 | 4,350.32 | 3,517.81 | 2,933.77 |
Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Appropriations | 538.04 | 526.09 | 418.48 | 334.78 | 358.70 | 179.35 |
P & L Balance carried down | 8,640.88 | 7,431.77 | 6,823.39 | 5,700.62 | 4,350.32 | 3,517.81 |
Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 95.65 |
Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Equity Dividend (%) | 2,000.00 | 2,500.00 | 1,700.00 | 1,500.00 | 1,250.00 | 800.00 |
Dividend Per Share(Rs) | 40.00 | 50.00 | 34.00 | 30.00 | 25.00 | 16.00 |
Earnings Per Share-Unit Curr | 146.14 | 94.90 | 128.92 | 140.95 | 105.76 | 66.90 |
Earnings Per Share(Adj)-Unit Curr | 146.14 | 94.90 | 128.92 | 140.95 | 105.76 | 66.90 |
Book Value | 882.86 | 782.09 | 731.38 | 637.87 | 525.34 | 457.15 |
Book Value(Adj)-Unit Curr | 882.86 | 782.09 | 731.38 | 637.87 | 525.34 | 457.15 |